Evidence map›Paper›PMID 37858589›Full record

ArticleThe Lancet. Global health2023

Research funding for newborn health and stillbirths, 2011-20: a systematic analysis of levels and trends.

Priyesh Agravat, Eva M Loucaides, Meghan Bruce Kumar, Anna Howells, Alexandra Molina García, Ismail Sebina, Núria Balanza, Elizabeth J A Fitchett, Joy E Lawn

Abstract read
In one paragraph

Article in The Lancet. Global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Updating unanswered questions for stillbirth research: refresh of the UK Stillbirth Priority Setting Partnership.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Priyesh AgravatSt George's, University of London, London, UK.
Eva M LoucaidesLondon School of Hygiene & Tropical Medicine, London, UK.
Meghan Bruce KumarLondon School of Hygiene & Tropical Medicine, London, UK; KEMRI-Wellcome Trust, Nairobi, Kenya.
Anna HowellsKing's College Hospital NHS Foundation Trust, London, UK.
Alexandra Molina GarcíaCentro de Salud San Fernando, Servicio Madrileño de Salud, Madrid, Spain.
Ismail SebinaQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Núria BalanzaISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Elizabeth J A FitchettLondon School of Hygiene & Tropical Medicine, London, UK. Electronic address: Elizabeth.Fitchett@lshtm.ac.uk.
Joy E LawnLondon School of Hygiene & Tropical Medicine, London, UK.

Funding

Department of HealthMedical Research Council MR/S004971/1Medical Research Council MR/V035274/1
6 · The paper itself

Abstract

backgroundWorldwide, an estimated 4·4 million newborn deaths and stillbirths occurred in 2020, and 98% of these deaths occurred in low-income and middle-income countries (LMICs). We aimed to analyse new research grants for newborns and stillbirth awarded by major funders in 2019-20, and all research funding allocated to LMIC-based institutions in 2011-20.

methodsFor this systematic analysis, we searched Dimensions, the world's largest research funding database, for grants relevant to neonatal and stillbirth research. Included grants were categorised by in-depth content analysis, with descriptive quantitative analyses by funder and recipient countries, research pipeline, topic, and year.

findingsGlobally, in 2019-20, major funders awarded a mean annual total of US$577·1 million per year for newborn and stillbirth research (mean total of 550 grants per year). $166·3 million (28·8%) of $577·1 million was directed to small and vulnerable newborn research, but only $8·4 million (1·5%) was directed to stillbirth research. The majority of funding, $537·0 million (93·0%), was allocated to organisations based in high-income countries. Between 2011 and 2020, LMIC-based recipients were named on 1985 grants from all funders worth $486·7 million, of which $73·1 million (15·0%) was allocated to small and vulnerable newborn research and $12·0 million (2·5%) was allocated to stillbirth research. Most LMIC funding supported preclinical or observational studies ($236·8 million [48·7%] of $486·7 million), with implementation research receiving only $13·9 million (2·9%).

interpretationAlthough investment in research related to neonatal health and stillbirths has increased between 2011 and 2020, there are marked disparities in distribution geographically, between major causes of mortality, and among research pipeline types. Stillbirth research received minimal funding in both high-income countries and LMICs, despite a similar number of deaths compared with neonates. Direct investment in LMIC-led research, especially for implementation research, could accelerate the slow global progress on stillbirth prevention and newborn survival.

fundingNone. TRANSLATIONS: For the French, German and Spanish translations of the abstract see Supplementary Materials section.

Indexed as

Perinatal DeathStillbirthFemaleFinancing, OrganizedHumansIncomeInfant HealthInfant, NewbornPregnancy

Identifiers

PMID37858589
PMCPMC10603613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.